Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Comparing two early therapy programs for young children with autism

Compares Early Start Denver Model and Pivotal Response Treatment in young children with autism.

Plain-language title generated from the registry record
Registry title: Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

Key facts

Where
Palo Alto, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 4 years old?

Source: NCT07522190, who can take part

Where in United States

  • Stanford UniversityPalo Alto, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Stanford University
Trial code
NCT07522190
Record updated
5 November 2026
Original description
The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may benefit most from each treatment. Additionally, after completing either the ESDM or PRT, some participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT). The study will include boys and girls 2 to 4 years 11 months old diagnosed with ASD. The main questions this study aims to answer are whether center-based ESDM and center-based PRT improve communication skills in young children with autism, and whether certain children respond better to one treatment approach than the other. Participants will be randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attend treatment session 4 days per week (~3 hours/day), complete developmental and autism assessments at baseline, 12 weeks, and 24 weeks, have a parent participate in weekly parent training sessions, and complete follow-up assessments at weeks 36 and 48.Read full original descriptionShow less

Randomized Controlled Trial of Center-Based Early Start Denver Model (ESDM) vs. Pivotal Response Treatment (PRT) in Children With Autism

The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may benefit most from each treatment. Additionally, after completing either the ESDM or PRT, some participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT). The study will include boys and girls 2 to 4 years 11 months old diagnosed with ASD. The main questions this study aims to answer are whether center-based ESDM and center-based PRT improve communication skills in young children with autism, and whether certain children respond better to one treatment approach than the other. Participants will be randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attend treatment session 4 days per week (~3 hours/day), complete developmental and autism assessments at baseline, 12 weeks, and 24 weeks, have a parent participate in weekly parent training sessions, and complete follow-up assessments at weeks 36 and 48.

Inclusion: Children must be between 2 and 4 years, 11 months of age at enrollment; Confirmed diagnosis of autism spectrum disorder based on standardized diagnostic assessments and clinical judgment; Demonstrated significant language delay as determined by standardized language measures; Ability to participate in study assessments and intervention procedures; At least one English-speaking parent or caregiver available to participate in parent training and research measures; Receiving stable community-based treatments or medications for at least one month prior to baseline, with no anticipated changes during the study period.

Exclusion: Prior adequate trial of PRT or ESDM; Current or lifetime diagnosis of a severe psychiatric disorder (e.g., bipolar disorder); Presence of an active or unstable medical condition (e.g., uncontrolled seizure disorder or significant cardiac disease); Child's primary language is not English; Receipt of more than 15 hours per week of in-home applied behavior analysis services; Inability to complete study assessments or procedures to obtain valid data.

ClinicalTrials.gov NCT07522190